logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
29/05/2025
Rubber futures main contract intraday decline expanded to 4%.
Latest
2 m ago
Spot gold touched $3300 per ounce on the upside, rising 0.40% intraday.
3 m ago
The National Medical Products Administration conditionally approves the marketing of Famiciribine capsules.
3 m ago
Recently, the National Medical Products Administration conditionally approved Jiangsu Hengrui Medicine Co., Ltd.'s application for a Category 1 innovative drug, Apple Acid Formatinib Capsules (trade name: Abit). This drug, in combination with Carilituzumab Monoclonal Antibody for injection, is used for the treatment of recurrent or metastatic cervical cancer patients who have previously failed platinum-based chemotherapy but have not received treatment with Bevacizumab Monoclonal Antibody. The approval of this drug provides new treatment options for patients. (National Medical Products Administration)
3 m ago
Alibaba-W (09988.HK) spent 9.995 million US dollars on May 28 to repurchase 682,400 shares.
3 m ago
The National Medical Products Administration has approved the marketing of intravenous phosphorolipanitanparonson.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.